89bio Inc

NASDAQ:ETNB   4:00:00 PM EDT
8.58
-0.34 (-3.81%)
4:20:00 PM EDT: $8.58 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

89bio Inc Stock, NASDAQ:ETNB

142 Sansome Street, 2nd floor, San Francisco, California 94104
United States of America
Phone: +1.415.432.9270
Number of Employees: 70
http://www.89bio.com

Description

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.